Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants

Trial Profile

Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 05 Jul 2017

At a glance

  • Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Rivaroxaban (Primary)
  • Indications Atrial fibrillation; Venous thromboembolism
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Jul 2015 Planned number of patients changed from 300 to 842, as reported by ClinicalTrials.gov.
    • 28 Jul 2015 Planned End Date changed from 1 Sep 2015 to 1 Dec 2015, as reported by ClinicalTrials.gov.
    • 28 Jul 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Sep 2015, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top